Suvretta Capital Management, LLC Allogene Therapeutics, Inc. Transaction History

Suvretta Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.65 - $15.29 $2.03 Million - $4.05 Million	-265,116 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$13.13 - $24.52 $3.48 Million - $6.5 Million	265,116 New	265,116 $3.96 Million
Q1 2021 May 17, 2021	SELL	$25.79 - $39.02 $12.5 Million - $18.9 Million	-483,200 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$25.24 - $43.45 $12.2 Million - $21 Million	483,200 New	483,200 $12.2 Million

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Suvretta Capital Management, LLC with notifications on news.